BioMarin Pharmaceutical Revenue 2010-2023 | BMRN

BioMarin Pharmaceutical annual/quarterly revenue history and growth rate from 2010 to 2023. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • BioMarin Pharmaceutical revenue for the quarter ending December 31, 2023 was $0.646B, a 20.22% increase year-over-year.
  • BioMarin Pharmaceutical revenue for the twelve months ending December 31, 2023 was $2.419B, a 15.42% increase year-over-year.
  • BioMarin Pharmaceutical annual revenue for 2023 was $2.419B, a 15.42% increase from 2022.
  • BioMarin Pharmaceutical annual revenue for 2022 was $2.096B, a 13.53% increase from 2021.
  • BioMarin Pharmaceutical annual revenue for 2021 was $1.846B, a 0.76% decline from 2020.
BioMarin Pharmaceutical Annual Revenue
(Millions of US $)
2023 $2,419
2022 $2,096
2021 $1,846
2020 $1,860
2019 $1,704
2018 $1,491
2017 $1,314
2016 $1,117
2015 $890
2014 $749
2013 $548
2012 $501
2011 $441
2010 $376
2009 $325
BioMarin Pharmaceutical Quarterly Revenue
(Millions of US $)
2023-12-31 $646
2023-09-30 $581
2023-06-30 $595
2023-03-31 $596
2022-12-31 $538
2022-09-30 $505
2022-06-30 $534
2022-03-31 $519
2021-12-31 $450
2021-09-30 $409
2021-06-30 $502
2021-03-31 $486
2020-12-31 $452
2020-09-30 $477
2020-06-30 $429
2020-03-31 $502
2019-12-31 $454
2019-09-30 $461
2019-06-30 $388
2019-03-31 $401
2018-12-31 $353
2018-09-30 $392
2018-06-30 $373
2018-03-31 $373
2017-12-31 $358
2017-09-30 $334
2017-06-30 $317
2017-03-31 $304
2016-12-31 $300
2016-09-30 $280
2016-06-30 $300
2016-03-31 $237
2015-12-31 $228
2015-09-30 $209
2015-06-30 $250
2015-03-31 $203
2014-12-31 $229
2014-09-30 $177
2014-06-30 $192
2014-03-31 $152
2013-12-31 $147
2013-09-30 $137
2013-06-30 $137
2013-03-31 $128
2012-12-31 $132
2012-09-30 $128
2012-06-30 $124
2012-03-31 $117
2011-12-31 $108
2011-09-30 $113
2011-06-30 $111
2011-03-31 $109
2010-12-31 $102
2010-09-30 $98
2010-06-30 $92
2010-03-31 $85
2009-12-31 $87
2009-09-30 $81
2009-06-30 $83
2009-03-31 $74
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $16.554B $2.419B
BioMarin Pharmaceutical Inc. focuses on the development and commercialization of treatments for serious life-threatening medical conditions, mostly for children. The company's portfolio comprises seven marketed products namely, Aldurazyme, Naglazyme, Kuvan a rare genetic enzyme deficiency disorder), Vimizim , Brineura, Palynziq and Voxzogo. BioMarin has a collaboration agreement with Sanofi's subsidiary Genzyme for Aldurazyme. Genzyme is BioMarin's sole customer for Aldurazyme and is responsible for marketing and selling Aldurazyme to third parties.?The newest drug in BioMarin's portfolio, Voxzogo for treating achondroplasia, the most common form of dwarfism. BioMarin's biologics license application (BLA) for Roctavian/valoctocogene roxaparvovec (valrox), a gene therapy for severe hemophilia A, was given a complete response letter (CRL) by the FDA.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $151.006B 15.11
Vertex Pharmaceuticals (VRTX) United States $108.091B 31.14
Bristol Myers Squibb (BMY) United States $106.506B 7.01
Regeneron Pharmaceuticals (REGN) United States $105.761B 25.64
Gilead Sciences (GILD) United States $90.156B 10.77
CSL (CSLLY) Australia $89.218B 0.00
GSK (GSK) United Kingdom $88.077B 11.11
Moderna (MRNA) United States $41.125B 0.00
Biogen (BIIB) United States $30.819B 14.39
Argenex SE (ARGX) Netherlands $23.577B 0.00
BioNTech SE (BNTX) Germany $21.799B 22.26
Illumina (ILMN) United States $21.261B 153.79
Genmab (GMAB) Denmark $20.371B 26.13
Alnylam Pharmaceuticals (ALNY) United States $19.140B 0.00
BeiGene (BGNE) Cayman Islands $14.701B 0.00
Incyte (INCY) United States $12.697B 21.10
Sarepta Therapeutics (SRPT) United States $12.043B 0.00
Exact Sciences (EXAS) United States $11.843B 0.00
Bio-Techne Corp (TECH) United States $10.752B 40.00
Repligen (RGEN) United States $10.253B 106.27
QIAGEN (QGEN) Netherlands $9.744B 20.17
Bio-Rad Laboratories (BIO.B) United States $9.474B 28.22
Legend Biotech (LEGN) United States $9.227B 0.00
Ascendis Pharma (ASND) Denmark $8.654B 0.00
Roivant Sciences (ROIV) United Kingdom $8.123B 0.00
Viking Therapeutics (VKTX) United States $8.122B 0.00
Cytokinetics (CYTK) United States $7.329B 0.00
Vaxcyte (PCVX) United States $7.309B 0.00
Exelixis (EXEL) United States $7.158B 36.89
Apellis Pharmaceuticals (APLS) United States $7.114B 0.00
Intra-Cellular Therapies (ITCI) United States $6.518B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $5.697B 0.00
Blueprint Medicines (BPMC) United States $5.488B 0.00
Zealand Pharma (ZLDPF) Denmark $5.203B 0.00
Halozyme Therapeutics (HALO) United States $5.092B 15.72
Krystal Biotech (KRYS) United States $4.928B 0.00
Nuvalent (NUVL) United States $4.852B 0.00
Biohaven (BHVN) United States $4.593B 0.00
Immunovant (IMVT) United States $4.567B 0.00
Alkermes (ALKS) Ireland $4.474B 23.91
Insmed (INSM) United States $4.012B 0.00
Iovance Biotherapeutics (IOVA) United States $3.924B 0.00
Apogee Therapeutics (APGE) United States $3.842B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.741B 0.00
Arcellx (ACLX) United States $3.703B 0.00
Axsome Therapeutics (AXSM) United States $3.635B 0.00
SpringWorks Therapeutics (SWTX) United States $3.630B 0.00
Fortrea Holdings (FTRE) United States $3.473B 0.00
ImmunityBio (IBRX) United States $3.451B 0.00
Amicus Therapeutics (FOLD) United States $3.376B 0.00
Xenon Pharmaceuticals (XENE) Canada $3.218B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $3.199B 0.00
IDEAYA Biosciences (IDYA) United States $3.170B 0.00
Immunocore Holdings (IMCR) United Kingdom $3.072B 0.00
ACADIA Pharmaceuticals (ACAD) United States $2.931B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $2.901B 0.00
Arvinas (ARVN) United States $2.791B 0.00
Denali Therapeutics (DNLI) United States $2.767B 0.00
Certara (CERT) United States $2.743B 59.17
MorphoSys AG (MOR) Germany $2.738B 0.00
Beam Therapeutics (BEAM) United States $2.713B 0.00
Merus (MRUS) Netherlands $2.599B 0.00
CG Oncology (CGON) United States $2.595B 0.00
Intellia Therapeutics (NTLA) United States $2.524B 0.00
Kymera Therapeutics (KYMR) United States $2.413B 0.00
Rocket Pharmaceuticals (RCKT) United States $2.404B 0.00
Vericel (VCEL) United States $2.398B 0.00
Keros Therapeutics (KROS) United States $2.379B 0.00
Rhythm Pharmaceuticals (RYTM) United States $2.377B 0.00
Ginkgo Bioworks Holdings (DNA) United States $2.303B 0.00
Celldex Therapeutics (CLDX) United States $2.294B 0.00
Vera Therapeutics (VERA) United States $2.183B 0.00
Galapagos (GLPG) Belgium $2.155B 0.00
Guardant Health (GH) United States $2.153B 0.00
Sana Biotechnology (SANA) United States $2.085B 0.00
Janux Therapeutics (JANX) United States $2.006B 0.00
Neumora Therapeutics (NMRA) United States $2.004B 0.00
Structure Therapeutics (GPCR) United States $1.965B 0.00
Twist Bioscience (TWST) United States $1.951B 0.00
NeoGenomics (NEO) United States $1.935B 0.00
Myriad Genetics (MYGN) United States $1.931B 0.00
Avidity Biosciences (RNA) United States $1.917B 0.00
Syndax Pharmaceuticals (SNDX) United States $1.822B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.818B 15.10
Geron (GERN) United States $1.802B 0.00
Bavarian Nordic (BVNRY) Denmark $1.747B 5.73
Inhibrx (INBX) United States $1.662B 0.00
Morphic Holding (MORF) United States $1.640B 0.00
Protagonist Therapeutics (PTGX) United States $1.632B 0.00
Dynavax Technologies (DVAX) United States $1.599B 0.00
Edgewise Therapeutics (EWTX) United States $1.596B 0.00
Zai Lab (ZLAB) China $1.576B 0.00
Kura Oncology (KURA) United States $1.555B 0.00
Arcus Biosciences (RCUS) United States $1.513B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $1.511B 0.00
ADMA Biologics Inc (ADMA) United States $1.483B 0.00
ANI Pharmaceuticals (ANIP) United States $1.466B 18.02
Disc Medicine (IRON) United States $1.456B 0.00
Autolus Therapeutics (AUTL) United Kingdom $1.433B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $1.410B 0.00
Immunome (IMNM) United States $1.390B 0.00
Akero Therapeutics (AKRO) United States $1.373B 0.00
Day One Biopharmaceuticals (DAWN) United States $1.356B 0.00
Vir Biotechnology (VIR) United States $1.346B 0.00
Prothena (PRTA) Ireland $1.330B 0.00
MannKind (MNKD) United States $1.328B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $1.290B 0.00
Belite Bio (BLTE) United States $1.267B 0.00
AbCellera Biologics (ABCL) Canada $1.256B 0.00
Ligand Pharmaceuticals (LGND) United States $1.215B 15.05
Liquidia Technologies (LQDA) United States $1.210B 0.00
Deciphera Pharmaceuticals (DCPH) United States $1.197B 0.00
Mirum Pharmaceuticals (MIRM) United States $1.171B 0.00
Scholar Rock Holding (SRRK) United States $1.168B 0.00
Tarsus Pharmaceuticals (TARS) United States $1.158B 0.00
MiMedx (MDXG) United States $1.120B 254.00
Viridian Therapeutics (VRDN) United States $1.090B 0.00
89BIO (ETNB) United States $1.047B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $1.028B 0.00
Kyverna Therapeutics (KYTX) United States $1.015B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $1.000B 0.00
REGENXBIO (RGNX) United States $0.963B 0.00
Immatics (IMTX) Germany $0.963B 0.00
CARGO Therapeutics (CRGX) United States $0.938B 0.00
Abivax SA (ABVX) France $0.934B 0.00
Oric Pharmaceuticals (ORIC) United States $0.907B 0.00
Arcutis Biotherapeutics (ARQT) United States $0.897B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.865B 0.00
Pliant Therapeutics (PLRX) United States $0.852B 0.00
Tyra Biosciences (TYRA) United States $0.848B 0.00
Praxis Precision Medicines (PRAX) United States $0.823B 0.00
Cytek Biosciences (CTKB) United States $0.823B 0.00
Cabaletta Bio (CABA) United States $0.818B 0.00
Tango Therapeutics (TNGX) United States $0.801B 0.00
Prime Medicine (PRME) United States $0.799B 0.00
PureTech Health (PRTC) United States $0.794B 0.00
HilleVax (HLVX) United States $0.787B 0.00
EnGene Holdings (ENGN) United States $0.784B 0.00
Pharming Group (PHGUF) Netherlands $0.783B 0.00
Astria Therapeutics (ATXS) United States $0.743B 0.00
Zymeworks (ZYME) United States $0.739B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.737B 0.00
Pharming Group (PHAR) Netherlands $0.728B 0.00
Longboard Pharmaceuticals (LBPH) United States $0.724B 0.00
Cullinan Oncology (CGEM) United States $0.723B 0.00
Aerovate Therapeutics (AVTE) United States $0.715B 0.00
Allogene Therapeutics (ALLO) United States $0.712B 0.00
Applied Therapeutics (APLT) United States $0.706B 0.00
WAVE Life Sciences (WVE) Singapore $0.692B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.687B 0.00
Fate Therapeutics (FATE) United States $0.681B 0.00
Novavax (NVAX) United States $0.659B 0.00
CureVac (CVAC) Germany $0.658B 0.00
ACELYRIN, INC (SLRN) United States $0.647B 0.00
Mineralys Therapeutics (MLYS) United States $0.637B 0.00
Nurix Therapeutics (NRIX) United States $0.637B 0.00
Neurogene (NGNE) United States $0.636B 0.00
Northwest Biotherapeutics (NWBO) United States $0.634B 0.00
Nuvation Bio (NUVB) United States $0.628B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.614B 0.00
Olema Pharmaceuticals (OLMA) United States $0.612B 0.00
Cogent Biosciences (COGT) United States $0.606B 0.00
Castle Biosciences (CSTL) United States $0.593B 0.00
Editas Medicine (EDIT) United States $0.591B 0.00
Absci (ABSI) United States $0.588B 0.00
AnaptysBio (ANAB) United States $0.578B 0.00
GH Research (GHRS) Ireland $0.577B 0.00
Travere Therapeutics (TVTX) United States $0.576B 0.00
Alector (ALEC) United States $0.571B 0.00
ArriVent BioPharma (AVBP) United States $0.569B 0.00
Fulcrum Therapeutics (FULC) United States $0.565B 0.00
ALX Oncology Holdings (ALXO) United States $0.561B 0.00
C4 Therapeutics (CCCC) United States $0.545B 0.00
Voyager Therapeutics (VYGR) United States $0.544B 3.24
Biomea Fusion (BMEA) United States $0.534B 0.00
Mersana Therapeutics (MRSN) United States $0.522B 0.00
Solid Biosciences (SLDB) United States $0.512B 0.00
IGM Biosciences (IGMS) United States $0.510B 0.00
Revance Therapeutics (RVNC) United States $0.490B 0.00
Nkarta (NKTX) United States $0.488B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.488B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.483B 0.00
Alto Neuroscience (ANRO) United States $0.483B 0.00
Stoke Therapeutics (STOK) United States $0.476B 0.00
Replimune (REPL) United States $0.472B 0.00
Oculis Holding AG (OCS) Switzerland $0.470B 0.00
Dianthus Therapeutics (DNTH) United States $0.467B 0.00
Entrada Therapeutics (TRDA) United States $0.462B 0.00
Caribou Biosciences (CRBU) United States $0.457B 0.00
MaxCyte (MXCT) United States $0.452B 0.00
Arbutus Biopharma (ABUS) United States $0.447B 0.00
Ocugen (OCGN) United States $0.444B 0.00
ITeos Therapeutics (ITOS) United States $0.443B 0.00
Avid Bioservices (CDMO) United States $0.429B 0.00
PepGen (PEPG) United States $0.425B 0.00
Celcuity (CELC) United States $0.424B 0.00
Shattuck Labs (STTK) United States $0.420B 0.00
Jasper Therapeutics (JSPR) United States $0.420B 0.00
Inozyme Pharma (INZY) United States $0.419B 0.00
Adaptive Biotechnologies (ADPT) United States $0.418B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.408B 0.00
Invivyd (IVVD) United States $0.403B 0.00
Mesoblast (MESO) Australia $0.399B 0.00
Terns Pharmaceuticals (TERN) United States $0.398B 0.00
Anavex Life Sciences (AVXL) United States $0.397B 0.00
MeiraGTx Holdings (MGTX) United States $0.396B 0.00
TScan Therapeutics (TCRX) United States $0.383B 0.00
Tenaya Therapeutics (TNYA) United States $0.379B 0.00
Anika Therapeutics (ANIK) United States $0.377B 0.00
Kodiak Sciences (KOD) United States $0.373B 0.00
MEREO BIOPHARMA (MREO) United Kingdom $0.369B 0.00
Annexon (ANNX) United States $0.366B 0.00
Third Harmonic Bio (THRD) United States $0.362B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.359B 0.00
Humacyte (HUMA) United States $0.359B 0.00
FibroBiologics (FBLG) United States $0.357B 0.00
Urogen Pharma (URGN) United States $0.356B 0.00
Amarin (AMRN) Ireland $0.356B 0.00
Precigen (PGEN) United States $0.348B 0.00
Ventyx Biosciences (VTYX) United States $0.347B 0.00
Adlai Nortye (ANL) Cayman Islands $0.335B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.331B 0.00
Nautilus Biotechnology (NAUT) United States $0.327B 0.00
Kamada (KMDA) Israel $0.321B 24.30
Atea Pharmaceuticals (AVIR) United States $0.317B 0.00
Erasca (ERAS) United States $0.299B 0.00
Adverum Biotechnologies (ADVM) United States $0.294B 0.00
Verastem (VSTM) United States $0.293B 0.00
Rapt Therapeutics (RAPT) United States $0.292B 0.00
Aura Biosciences (AURA) United States $0.292B 0.00
Inovio Pharmaceuticals (INO) United States $0.289B 0.00
ChromaDex (CDXC) United States $0.289B 0.00
AC Immune (ACIU) Switzerland $0.281B 0.00
Gossamer Bio (GOSS) United States $0.277B 0.00
Compass Therapeutics (CMPX) United States $0.272B 0.00
Poseida Therapeutics (PSTX) United States $0.271B 0.00
Puma Biotechnology (PBYI) United States $0.270B 12.17
XOMA (XOMA) United States $0.269B 0.00
Greenwich LifeSciences (GLSI) United States $0.261B 0.00
Sutro Biopharma (STRO) United States $0.261B 0.00
Coherus BioSciences (CHRS) United States $0.259B 0.00
Werewolf Therapeutics (HOWL) United States $0.258B 0.00
UniQure (QURE) Netherlands $0.255B 0.00
2seventy Bio (TSVT) United States $0.255B 0.00
Gritstone Bio (GRTS) United States $0.254B 0.00
Scilex Holding (SCLX) United States $0.251B 0.00
X4 Pharmaceuticals (XFOR) United States $0.244B 0.00
Elevation Oncology (ELEV) United States $0.243B 0.00
XBiotech (XBIT) United States $0.243B 0.00
Codexis (CDXS) United States $0.243B 0.00
Cardiff Oncology (CRDF) United States $0.241B 0.00
23andMe Holding (ME) United States $0.236B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.234B 0.00
Trevi Therapeutics (TRVI) United States $0.234B 0.00
Akoya Biosciences (AKYA) United States $0.228B 0.00
CorMedix Inc (CRMD) United States $0.225B 0.00
Agenus (AGEN) United States $0.225B 0.00
G1 Therapeutics (GTHX) United States $0.224B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.222B 77.20
Acumen Pharmaceuticals (ABOS) United States $0.217B 0.00
Opthea (OPT) Australia $0.217B 0.00
Compugen (CGEN) Israel $0.217B 0.00
INmune Bio (INMB) United States $0.214B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.214B 0.00
Ovid Therapeutics (OVID) United States $0.212B 0.00
Prima BioMed (IMMP) Australia $0.210B 0.00
Alimera Sciences (ALIM) United States $0.203B 0.00
Design Therapeutics (DSGN) United States $0.202B 0.00
Abeona Therapeutics (ABEO) United States $0.201B 0.00
Innate Pharma S.A (IPHA) France $0.197B 0.00
Inventiva S.A (IVA) France $0.197B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.195B 0.00
Renovaro (RENB) United States $0.195B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.188B 0.00
Omega Therapeutics (OMGA) United States $0.187B 0.00
Adicet Bio (ACET) United States $0.184B 0.00
GENFIT S.A (GNFT) France $0.183B 0.00
ScPharmaceuticals (SCPH) United States $0.177B 0.00
Repare Therapeutics (RPTX) Canada $0.168B 0.00
Adocia (ADOCY) France $0.166B 0.00
Rani Therapeutics Holdings (RANI) United States $0.159B 0.00
Genelux (GNLX) United States $0.159B 0.00
Lifecore Biomedical (LFCR) United States $0.156B 0.00
Molecular Partners AG (MOLN) Switzerland $0.154B 0.00
Spyre Therapeutics (SYRE) United States $0.152B 0.00
DBV Technologies S.A (DBVT) France $0.150B 0.00
I-Mab (IMAB) China $0.148B 0.00
Vor Biopharma (VOR) $0.147B 0.00
Nuvectis Pharma (NVCT) United States $0.147B 0.00
BioAtla (BCAB) United States $0.144B 0.00
CytomX Therapeutics (CTMX) United States $0.143B 0.00
Cellectis S.A (CLLS) France $0.143B 0.00
BeyondSpring (BYSI) United States $0.141B 0.00
PDS Biotechnology (PDSB) United States $0.139B 0.00
LENZ Therapeutics (LENZ) United States $0.139B 0.00
Ocean Biomedical (OCEA) United States $0.139B 0.00
TELA Bio (TELA) United States $0.137B 0.00
Syros Pharmaceuticals (SYRS) United States $0.132B 0.00
Bluebird Bio (BLUE) United States $0.131B 0.00
ATyr Pharma (LIFE) United States $0.130B 0.00
NGM Biopharmaceuticals (NGM) United States $0.129B 0.00
Emergent Biosolutions (EBS) United States $0.127B 0.00
Genetron Holdings (GTH) China $0.127B 0.00
Clearside Biomedical (CLSD) United States $0.126B 0.00
Annovis Bio (ANVS) United States $0.125B 0.00
Kinnate Biopharma (KNTE) United States $0.124B 0.00
Seer (SEER) United States $0.119B 0.00
CervoMed (CRVO) United States $0.118B 0.00
VistaGen Therapeutics (VTGN) United States $0.118B 0.00
Immunic (IMUX) United States $0.115B 0.00
Seres Therapeutics (MCRB) United States $0.114B 0.00
Allakos (ALLK) United States $0.113B 0.00
Oncobiologics (OTLK) United States $0.113B 0.00
Sagimet Biosciences (SGMT) United States $0.112B 0.00
IO Biotech (IOBT) Denmark $0.111B 0.00
Adagene (ADAG) China $0.111B 0.00
Vincerx Pharma (VINC) United States $0.109B 0.00
Sangamo Therapeutics (SGMO) United States $0.108B 0.00
Lantern Pharma (LTRN) United States $0.108B 0.00
DiaMedica Therapeutics (DMAC) United States $0.103B 0.00
Alpha Teknova (TKNO) United States $0.102B 0.00
Cartesian Therapeutics (RNAC) United States $0.101B 0.00
Vigil Neuroscience (VIGL) United States $0.100B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.100B 0.00
Athira Pharma (ATHA) United States $0.099B 0.00
Eton Pharmaceuticals (ETON) United States $0.098B 0.00
BioHarvest Sciences (CNVCF) Canada $0.098B 0.00
Celularity (CELU) United States $0.097B 0.00
Zura Bio (ZURA) United States $0.097B 0.00
Spero Therapeutics (SPRO) United States $0.093B 3.46
AN2 Therapeutics (ANTX) United States $0.093B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.093B 0.00
Coya Therapeutics (COYA) United States $0.089B 0.00
BioXcel Therapeutics (BTAI) United States $0.087B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.086B 0.00
Rezolute (RZLT) United States $0.084B 0.00
Cue Biopharma (CUE) United States $0.083B 0.00
Provectus Biopharmaceuticals (PVCT) United States $0.083B 0.00
Vaxxinity (VAXX) United States $0.082B 0.00
Affimed (AFMD) Germany $0.079B 0.00
Elutia (ELUT) United States $0.078B 0.00
Aligos Therapeutics (ALGS) United States $0.077B 0.00
Oncolytics Biotech (ONCY) Canada $0.076B 0.00
Connect Biopharma Holdings (CNTB) United States $0.073B 0.00
Intensity Therapeutics (INTS) United States $0.073B 0.00
Equillium (EQ) United States $0.073B 0.00
Instil Bio (TIL) United States $0.072B 0.00
Kronos Bio (KRON) United States $0.072B 0.00
Cognition Therapeutics (CGTX) United States $0.071B 0.00
Passage Bio (PASG) United States $0.071B 0.00
Immuneering (IMRX) United States $0.070B 0.00
VTv Therapeutics (VTVT) United States $0.070B 0.00
Genenta Science S.p.A (GNTA) Italy $0.069B 0.00
InflaRx (IFRX) Germany $0.069B 0.00
Atara Biotherapeutics (ATRA) United States $0.067B 0.00
Landos Biopharma (LABP) United States $0.067B 0.00
Ikena Oncology (IKNA) United States $0.067B 0.00
Cidara Therapeutics (CDTX) United States $0.067B 0.00
MediciNova (MNOV) United States $0.067B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.067B 0.00
Kezar Life Sciences (KZR) United States $0.065B 0.00
Enzo Biochem (ENZ) United States $0.064B 0.00
Leap Therapeutics (LPTX) United States $0.063B 0.00
Turnstone Biologics (TSBX) United States $0.062B 0.00
Semper Paratus Acquisition (TVGN) United States $0.061B 0.00
HCW Biologics (HCWB) United States $0.061B 0.00
Beyond Air (XAIR) United States $0.061B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.061B 0.00
HOOKIPA Pharma (HOOK) United States $0.060B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.060B 0.00
Elicio Therapeutics (ELTX) United States $0.060B 0.00
Curis (CRIS) United States $0.059B 0.00
YS Biopharma (YS) China $0.059B 0.00
Immix Biopharma (IMMX) United States $0.058B 0.00
Bionano Genomics (BNGO) United States $0.057B 0.00
AVROBIO (AVRO) United States $0.057B 0.00
Carmell (CTCX) United States $0.056B 0.00
Rallybio (RLYB) United States $0.056B 0.00
NextCure (NXTC) United States $0.055B 0.00
Clene (CLNN) United States $0.054B 0.00
Aadi Bioscience (AADI) United States $0.054B 0.00
Precision BioSciences (DTIL) United States $0.052B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.051B 0.00
Achilles Therapeutics (ACHL) United Kingdom $0.051B 0.00
Ocuphire Pharma (OCUP) United States $0.050B 0.00
Apollomics (APLM) Taiwan $0.050B 0.00
Dare Bioscience (DARE) United States $0.049B 0.00
Checkpoint Therapeutics (CKPT) United States $0.049B 0.00
Quince Therapeutics (QNCX) United States $0.048B 0.00
Eyenovia (EYEN) United States $0.048B 0.00
Lexaria Bioscience (LEXX) Canada $0.047B 0.00
Estrella Immunopharma (ESLA) United States $0.046B 0.00
Dyadic (DYAI) United States $0.046B 0.00
Bolt Biotherapeutics (BOLT) United States $0.045B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $0.045B 0.00
Entera Bio (ENTX) Israel $0.045B 0.00
Candel Therapeutics (CADL) United States $0.043B 0.00
Gyre Therapeutics (GYRE) United States $0.043B 0.00
Pluri (PLUR) Israel $0.042B 0.00
NKGen Biotech (NKGN) United States $0.042B 0.00
OKYO Pharma (OKYO) $0.042B 0.00
BRIACELL THERAP (BCTX) Canada $0.041B 0.00
Cyclo Therapeutics (CYTH) United States $0.040B 0.00
IN8bio (INAB) United States $0.040B 0.00
Cara Therapeutics (CARA) United States $0.040B 0.00
Promis Neurosciences (PMN) Canada $0.037B 0.00
Gamida Cell (GMDA) United States $0.036B 0.00
Biora Therapeutics (BIOR) United States $0.036B 0.00
Theratechnologies (THTX) Canada $0.034B 0.00
Galena Biopharma (SLS) United States $0.034B 0.00
EFFECTOR Therapeutics (EFTR) United States $0.033B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.033B 0.00
MiNK Therapeutics (INKT) United States $0.033B 0.00
Prenetics Global (PRE) Cayman Islands $0.033B 39.59
Femasys (FEMY) United States $0.032B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.032B 0.00
Evogene (EVGN) Israel $0.030B 0.00
Spruce Biosciences (SPRB) United States $0.029B 0.00
Aileron Therapeutics (ALRN) United States $0.028B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.028B 0.00
UNITY Biotechnology (UBX) United States $0.027B 0.00
Orgenesis (ORGS) United States $0.027B 0.00
Lisata Therapeutics (LSTA) United States $0.026B 0.00
Sensei Biotherapeutics (SNSE) United States $0.026B 0.00
Forte Biosciences (FBRX) United States $0.026B 0.00
Aptose Biosciences (APTO) Canada $0.025B 0.00
ARCA Biopharma (ABIO) United States $0.025B 0.00
CalciMedica (CALC) United States $0.024B 0.00
Lumos Pharma (LUMO) United States $0.023B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.023B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.023B 0.00
Aprea Therapeutics (APRE) United States $0.022B 0.00
SAB Biotherapeutics (SABS) United States $0.022B 0.00
KALA BIO (KALA) United States $0.021B 0.00
NeuroBo Pharmaceuticals (NRBO) United States $0.021B 0.00
Synlogic (SYBX) United States $0.021B 0.00
Galecto (GLTO) Denmark $0.020B 0.00
BioAffinity Technologies (BIAF) United States $0.020B 0.00
TRACON Pharmaceuticals (TCON) United States $0.020B 0.00
Senti Biosciences (SNTI) United States $0.019B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.019B 0.00
Xilio Therapeutics (XLO) United States $0.018B 0.00
Fortress Biotech (FBIO) United States $0.017B 0.00
Aytu BioPharma (AYTU) United States $0.017B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.017B 0.00
Talis Biomedical (TLIS) United States $0.016B 0.00
NuCana (NCNA) United Kingdom $0.016B 0.00
IMMURON (IMRN) Australia $0.016B 0.00
Purple Biotech (PPBT) Israel $0.016B 0.00
TFF Pharmaceuticals (TFFP) United States $0.015B 0.00
Cocrystal Pharma (COCP) United States $0.015B 0.00
Acorda Therapeutics (ACOR) United States $0.015B 0.00
RenovoRx (RNXT) United States $0.014B 0.00
VBI Vaccines (VBIV) United States $0.014B 0.00
ABVC BioPharma (ABVC) United States $0.014B 0.00
Telesis Bio (TBIO) United States $0.013B 0.00
Edesa Biotech (EDSA) Canada $0.013B 0.00
Benitec Biopharma (BNTC) United States $0.013B 0.00
Evaxion Biotech (EVAX) Denmark $0.013B 0.00
Eterna Therapeutics (ERNA) United States $0.012B 0.00
Elevai Labs (ELAB) United States $0.012B 0.00
Imunon (IMNN) United States $0.011B 0.00
Monopar Therapeutics (MNPR) United States $0.011B 0.00
BioCardia (BCDA) United States $0.011B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.011B 0.00
Organovo Holdings (ONVO) United States $0.011B 0.00
Genetic Technologies (GENE) Australia $0.010B 0.00
Moleculin Biotech (MBRX) United States $0.010B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.010B 0.00
Cadrenal Therapeutics (CVKD) United States $0.010B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.010B 0.00
Hepion Pharmaceuticals (HEPA) United States $0.010B 0.00
Galera Therapeutics (GRTX) United States $0.010B 0.00
Psyence Biomedical (PBM) United States $0.010B 0.00
AEterna Zentaris (AEZS) Canada $0.010B 0.00
Mustang Bio (MBIO) United States $0.010B 0.00
Portage Biotech (PRTG) $0.009B 0.00
Longeveron (LGVN) United States $0.009B 0.00
Bionomics (BNOX) Australia $0.009B 0.00
Prana Biotechnology (ATHE) Australia $0.008B 0.00
Cyclerion Therapeutics (CYCN) United States $0.008B 0.00
Chemomab Therapeutics (CMMB) Israel $0.008B 0.00
Virios Therapeutics (VIRI) United States $0.008B 0.00
Trevena (TRVN) United States $0.008B 0.00
Eiger BioPharmaceuticals (EIGR) United States $0.008B 0.00
Atrinsic (PTIX) United States $0.008B 0.00
AquaBounty Technologies (AQB) United States $0.008B 0.00
Pasithea Therapeutics (KTTA) United States $0.008B 0.00
Seelos Therapeutics (SEEL) United States $0.007B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.007B 0.00
Alzamend Neuro (ALZN) United States $0.007B 0.00
Vaccinex (VCNX) United States $0.007B 0.00
Biorestorative Therapies (BRTX) United States $0.007B 0.00
Hoth Therapeutics (HOTH) United States $0.006B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.006B 0.00
Soligenix (SNGX) United States $0.006B 0.00
Pulmatrix (PULM) United States $0.006B 0.00
GT Biopharma (GTBP) United States $0.006B 0.00
Kineta (KA) United States $0.006B 0.00
NexImmune (NEXI) United States $0.006B 0.00
Ensysce Biosciences (ENSC) United States $0.006B 0.00
Enveric Biosciences (ENVB) United States $0.006B 0.00
Biofrontera (BFRI) United States $0.006B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.006B 0.00
Silo Pharma (SILO) United States $0.006B 0.00
Titan Pharmaceuticals (TTNP) United States $0.005B 0.00
Exicure (XCUR) United States $0.005B 0.37
Novogen (KZIA) Australia $0.005B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.005B 0.00
Tharimmune (THAR) United States $0.005B 0.00
Bright Minds Biosciences (DRUG) United States $0.005B 0.00
Lipella Pharmaceuticals (LIPO) United States $0.005B 0.00
Artelo Biosciences (ARTL) United States $0.005B 0.00
Virpax Pharmaceuticals (VRPX) United States $0.005B 0.00
GENPREX (GNPX) United States $0.004B 0.00
Synaptogenix (SNPX) United States $0.004B 0.00
GeoVax Labs (GOVX) United States $0.004B 0.00
Notable Labs (NTBL) United States $0.004B 0.00
PaxMedica (PXMD) United States $0.004B 0.00
Biophytis SA (BPTS) France $0.004B 0.00
Kintara Therapeutics (KTRA) United States $0.004B 0.00
Palisade Bio (PALI) United States $0.003B 0.00
Avalon GloboCare (ALBT) United States $0.003B 0.00
Onconetix (ONCO) United States $0.003B 0.00
ARAVIVE, INC (ARAV) United States $0.003B 0.00
First Wave BioPharma (FWBI) United States $0.003B 0.00
Invo BioScience (INVO) United States $0.003B 0.00
CNS Pharmaceuticals (CNSP) United States $0.002B 0.00
Adial Pharmaceuticals (ADIL) United States $0.002B 0.00
ThermoGenesis Holdings (THMO) United States $0.002B 0.00
Allarity Therapeutics (ALLR) United States $0.002B 0.00
Windtree Therapeutics (WINT) United States $0.002B 0.00
NeuBase Therapeutics (NBSE) United States $0.002B 0.00
Aptevo Therapeutics (APVO) United States $0.002B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.002B 0.00
Sunshine Biopharma (SBFM) Canada $0.002B 0.00
Dermata Therapeutics (DRMA) United States $0.001B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.001B 0.00
Bone Biologics (BBLG) United States $0.001B 0.00
Tenax Therapeutics (TENX) United States $0.001B 0.00
Cingulate (CING) United States $0.001B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.001B 0.00
TC BioPharm (Holdings) (TCBP) United Kingdom $0.001B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.001B 0.00
180 Life Sciences (ATNF) United States $0.001B 0.00
Revelation Biosciences (REVB) United States $0.001B 0.00
GRI Bio (GRI) United States $0.000B 0.00
Sinovac Biotech (SVA) China $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
Alvotech (ALVO) $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
Mainz Biomed (MYNZ) Germany $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pharvaris (PHVS) Netherlands $0.000B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00